Page last updated: 2024-08-25

acamprosate and Alcohol Drinking

acamprosate has been researched along with Alcohol Drinking in 95 studies

Research

Studies (95)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (2.11)	18.7374
1990's	8 (8.42)	18.2507
2000's	33 (34.74)	29.6817
2010's	40 (42.11)	24.3611
2020's	12 (12.63)	2.80

Authors

Authors	Studies
Biernacka, JM; Choi, DS; Frye, MA; Geske, JR; Ho, MF; Karpyak, VM; Li, H; Moon, I; Oesterle, TS; Seppala, MD; Skime, MK; Wei, L; Weinshilboum, RM; Zhang, C; Zhang, L	1
Kranzler, HR; Mann, K; Nakovics, H; Roos, CR; Votaw, VR; Witkiewitz, K	1
Cheng, A; Habtemariam, Z; Kelleher, C; Lewis, H; Lovendoski, J; Strathie, K; Tyson, LD	1
Giri, S; Sundaram, S	1
Addolorato, G; Antonelli, M; Sestito, L; Tarli, C	1
Lewis, H; Tyson, LD	1
Bain, PA; Busch, AB; Huskamp, HA; Hyland, CJ; McDowell, MJ	1
Agabio, R; Minozzi, S; Rösner, S; Saulle, R	1
Matsushita, S	1
Bobashev, G; Coffey, CP; Edlund, MD; Jonas, DE; Kennedy, SM; Kuznacic, K; McPheeters, M; O'Connor, EA; Riley, S; Voisin, C	1
Anton, RF; Falk, DE; Hasin, DS; Heather, N; Kranzler, HR; Litten, RZ; Mann, KF; O'Malley, SS; Witkiewitz, K	1
Paille, F	1
Biernacka, J; Choi, DS; Frye, M; Geske, JR; Ho, MF; Karpyak, VM; Li, H; Moon, I; Wei, L; Weinshilboum, R; Wen, Z; Zhang, C; Zhang, L; Zhou, Y	1
Biernacka, JM; Choi, DS; Geske, JR; Hinton, DJ; Hitschfeld, MJ; Ho, AMC; Karpyak, VM; Vázquez, MS	1
Ericson, M; Lidö, HH; Söderpalm, B	1
Heinz, A; Hoffmann, S; Leménager, T; Mann, K; Nakovics, H; Roos, CR; Witkiewitz, K	1
Donoghue, K	1
Fang, HM; Kroener, S; Melugin, PR; Pradhan, G; Weber, R; Wu, F	1
Minozzi, S; Rösner, S; Saulle, R	1
Anton, RF; Baker, NL; Bandyopadhyay, D; DeSantis, SM; Prisciandaro, JJ; Randall, PK	1
O'Connor, PG; O'Malley, SS	1
Hirouchi, M; Oka, M; Oyama, T; Sugahara, S; Tamura, M	1
Liang, J; Olsen, RW	1
Braciszewski, JM; Falk, D; Kranzler, HR; O'Malley, SS; Stout, RL; Subbaraman, MS	1
Fucito, LM; Gueorguieva, R; Hoffmann, S; Mann, K; O'Connor, PG; O'Malley, SS; Weisner, C; Wu, R	1
Amato, RJ; Hulin, MW; Lawrence, MN; Weed, PF; Winsauer, PJ	1
Lieb, M; Soyka, M	1
Carrasco, A; Hu, W; Kroener, S; Morris, B	1
Frohe, T; Kirouac, M; Maisto, SA; McCallion, E; Vowles, KE; Witkiewitz, K	1
Mitani, Y; Nabeshima, T; Nakamura, T; Oki, Y; Shimizu, C	1
Anton, RF; Fitzmaurice, GM; Griffin, ML; McHugh, RK; Weiss, RD	1
Aguiar, FS; Choi, DS; Hinton, DJ; Ho, AM; Jia, YF; Karpyak, VM; Qiu, Y; Weinshilboum, RM	1
Mann, K; Roos, CR; Witkiewitz, K	1
Kiefer, F; Littleton, J; Mann, K; Spanagel, R	1
Abernathy, KE; Bartlett, SE; Chandler, LJ; Medina, B; Simms, JA; Steensland, P; Wise, R	1
Brzezinska, WJ; Cohn, KA; Demeyer, MR; Gupta, T; Martinez, M; Miller, SA; Patel, KY; Revis, AA; Rhodes, JS; Syed, YM	1
Garbutt, JC	1
Czachowski, CL; Delory, MJ	1
Kenna, GA; Leggio, L; Ray, LA; Swift, RM	1
Franck, J; Hammarberg, A; Jayaram-Lindström, N; Nylander, I; Reid, MS; Zhou, Q	1
Chau, P; Ericson, M; Höifödt-Lidö, H; Löf, E; Söderpalm, B	1
Couper, D; Donovan, D; Gueorguieva, R; Krystal, JH; O'Malley, SS; Rounsaville, BJ; Wu, R	2
Kiefer, F; Mann, K	1
Leonardi-Essmann, F; Marston, HM; Sommer, WH; Spanagel, R; Vengeliene, V	1
Falk, D; Fertig, J; Johnson, B; Litten, RZ; Liu, L; Mattson, M; Ryan, M; Stout, R; Wang, XQ	1
Longabaugh, R; O'Malley, SS; Wirtz, PW; Zywiak, WH	1
Capone, C; Kahler, CW; O'Malley, SS; Swift, RM	1
Choi, DS; Hinton, DJ; Lee, MR; Macura, SI; Mishra, PK; Port, JD; Wu, J	1
Bowen, S; Donovan, DM; Witkiewitz, K	1
Frommann, N; Gaebel, W; Kuhlmann, T; Lieb, B; Scherbaum, N; Schifano, F; Specka, M; Wobrock, T	1
Brager, A; Glass, JD; Prosser, RA	1
Dean, E; Dwan, R; Jane, JS; O'Brien, E; Petrakis, I; Ralevski, E	1
Brager, AJ; Glass, JD; Prosser, RA	1
Brady, KT; Brown, DG; Chiuzan, C; DeSantis, SM; Prisciandaro, JJ; Tolliver, BK	1
Ericson, M; Lidö, HH; Marston, H; Söderpalm, B	1
Bandyopadhyay, D; DeSantis, SM; Prisciandaro, JJ	1
Bühler, KM; Echeverry-Alzate, V; Giné, E; Gorriti, MÁ; Huertas, E; López-Moreno, JA; Olmos, P; Rodríguez de Fonseca, F; Santos, Á; Tuda-Arízcun, M	1
Bujarski, S; Lunny, K; O'Malley, SS; Ray, LA	1
Heyser, CJ; Koob, GF; Moc, K	1
Han, BD; Kim, MJ; Kim, SG; Park, JM; Stromberg, MF	1
Chick, J; Landron, F; Lehert, P	1
Brasser, SM; Houtsmuller, EJ; McCaul, ME	1
Geerlings, PJ; Koeter, MW; Lehert, P; van den Brink, W; Verheul, R	1
O'Brien, CP	1
Lee, TH	1
Kenna, GA; McGeary, JE; Swift, RM	1
Abarca, C; Albrecht, U; Depner, M; Holzberg, D; Lascorz, J; Lathrop, M; Magnone, MC; Matsuda, F; Pendyala, G; Sanchis-Segura, C; Schreiber, S; Schumann, G; Soyka, M; Spanagel, R; Zghoul, T	1
Bachteler, D; Ciccocioppo, R; Danysz, W; Economidou, D; Spanagel, R	1
Kaminska, E; Mikolajczak, P; Okulicz-Kozaryn, I; Piorunska-Mikolajczak, A; Piorunska-Stolzmann, M	1
Escher, T; Mittleman, G	1
Jahn, H; Kiefer, F; Nakovics, H; Otte, C; Wiedemann, K	1
Balester-Mouret, S; Batel, P	1
Füllgrabe, MW; Spanagel, R; Vengeliene, V	1
Andreoli, M; Ashby, CR; Gardner, EL; Heidbreder, CA; Hutcheson, DM; Marcon, C	1
Lehert, P; Leucht, S; Rösner, S; Soyka, M	1
Blednov, YA; Harris, RA	1
Boismare, F; Chretien, P; Daoust, M; Durlach, J; Lhuintre, JP; Moore, N; Saligaut, C	1
Ades, J; Lejoyeux, M	1
Mann, K; Sass, H; Soyka, M; Zieglgänsberger, W	1
Allingham, K; Hölter, SM; Landgraf, R; Spanagel, R; Zieglgänsberger, W	1
Durbin, P; Heyser, CJ; Koob, GF; Schulteis, G	1
Farren, CK; O'Malley, SS	1
Fiellin, DA; O'Connor, PG; Reid, MC	1
Koob, GF	1
Czachowski, CL; Legg, BH; Samson, HH	1
Mackler, SA; O'Brien, CP; Stromberg, MF; Volpicelli, JR	1
Chester, JA; Froehlich, JC; Grahame, NJ; Li, TK; Lumeng, L	1
Hodge, CW; Koenig, HN; Nannini, MA; Olive, MF; Ou, CJ	1
Daoust, M; Ernouf, D; Narcisse, G; Poulain, D	1
De Witte, P; Durbin, P; Gewiss, M; Heidbreder, C; Opsomer, L	1
Boismare, F; Daoust, M; Ladure, P; Langrenon, S; Lhuintre, JP; Libert, C; Moore, N; Parot, P; Steru, L; Tran, G	1
Boismare, F; Daoust, M; Flipo, JL; Lhuintre, JP; Moore, N; Saligaut, C	1

Reviews

19 review(s) available for acamprosate and Alcohol Drinking

Article	Year
Perspectives on the pharmacological management of alcohol use disorder: Are the approved medications effective? European journal of internal medicine, 2022, Volume: 103 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Disulfiram; Humans; Naltrexone	2022
Integration of pharmacotherapy for alcohol use disorder treatment in primary care settings: A scoping review. Journal of substance abuse treatment, 2023, Volume: 144 Topics: Acamprosate; Adolescent; Alcohol Drinking; Alcoholism; Disulfiram; Humans; Naltrexone; Primary Health Care; Randomized Controlled Trials as Topic; United States	2023
Baclofen for alcohol use disorder. The Cochrane database of systematic reviews, 2023, 01-13, Volume: 1 Topics: Acamprosate; Adult; Alcohol Drinking; Alcoholism; Baclofen; Chronic Disease; Female; Humans; Male; Middle Aged; Naltrexone	2023
[Pharmacological Treatment for Alcohol Dependence]. Brain and nerve = Shinkei kenkyu no shinpo, 2023, Volume: 75, Issue:5 Topics: Acamprosate; Alcohol Drinking; Alcoholism; Ethanol; Humans; Narcotic Antagonists; Substance Withdrawal Syndrome	2023
Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis. JAMA, 2023, 11-07, Volume: 330, Issue:17 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Drug-Related Side Effects and Adverse Reactions; Humans; Naltrexone; Prospective Studies; Psychosocial Intervention; Quality of Life; United States	2023
The Glycine Receptor-A Functionally Important Primary Brain Target of Ethanol. Alcoholism, clinical and experimental research, 2017, Volume: 41, Issue:11 Topics: Acamprosate; Alcohol Drinking; Animals; Brain; Dopamine; Ethanol; Humans; Naltrexone; Receptors, Glycine; Taurine	2017
Baclofen for alcohol use disorder. The Cochrane database of systematic reviews, 2018, Nov-26, Volume: 11 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Baclofen; Craving; Depression; Female; GABA-B Receptor Agonists; Humans; Male; Middle Aged; Patient Dropouts; Randomized Controlled Trials as Topic; Recurrence	2018
Medications for unhealthy alcohol use: across the spectrum. Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism, 2011, Volume: 33, Issue:4 Topics: Acamprosate; Alcohol Drinking; Alcoholism; Animals; Disulfiram; Dopamine Agents; Fructose; Humans; Naltrexone; Selective Serotonin Reuptake Inhibitors; Taurine; Topiramate	2011
Alcohol use disorders and current pharmacological therapies: the role of GABA(A) receptors. Acta pharmacologica Sinica, 2014, Volume: 35, Issue:8 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Benzodiazepines; Disulfiram; Ethanol; Fructose; Humans; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Plant Preparations; Receptors, GABA-A; Taurine; Topiramate	2014
Recent Developments in Pharmacotherapy of Alcoholism. Pharmacopsychiatry, 2015, Volume: 48, Issue:4-5 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Anticonvulsants; Baclofen; Humans; Naltrexone; Narcotic Antagonists; Pharmacogenetics; Randomized Controlled Trials as Topic; Taurine; Varenicline	2015
Acamprosate: recent findings and future research directions. Alcoholism, clinical and experimental research, 2008, Volume: 32, Issue:7 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; gamma-Aminobutyric Acid; Glutamates; Humans; Neuroprotective Agents; Patient Selection; Secondary Prevention; Taurine	2008
The state of pharmacotherapy for the treatment of alcohol dependence. Journal of substance abuse treatment, 2009, Volume: 36, Issue:1 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Baclofen; Delayed-Action Preparations; Disulfiram; Fructose; Humans; Medication Adherence; Naltrexone; Taurine; Temperance; Topiramate	2009
Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy. Current pharmaceutical design, 2010, Volume: 16, Issue:19 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Drug Delivery Systems; Humans; Molecular Biology; Pharmacogenetics; Precision Medicine; Taurine	2010
Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients. Psychopharmacology, 2005, Volume: 178, Issue:2-3 Topics: Acamprosate; Adult; Age Factors; Aged; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Anxiety; Double-Blind Method; Ethanol; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; Motivation; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Sex Factors; Substance Withdrawal Syndrome; Taurine; Treatment Outcome	2005
Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2004, Nov-01, Volume: 61, Issue:21 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcohol-Related Disorders; Animals; Clinical Trials as Topic; Disulfiram; Excitatory Amino Acid Antagonists; Humans; Naltrexone; Narcotic Antagonists; Taurine	2004
Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes. Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:1 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Publication Bias; Secondary Prevention; Taurine	2008
Clinical evaluation of acamprosate to reduce alcohol intake. Alcohol and alcoholism (Oxford, Oxfordshire). Supplement, 1993, Volume: 2 Topics: Acamprosate; Alcohol Drinking; Alcoholism; Controlled Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Multicenter Studies as Topic; Taurine	1993
New therapies for alcohol problems: application to primary care. The American journal of medicine, 2000, Feb-15, Volume: 108, Issue:3 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcohol-Related Disorders; Clinical Trials as Topic; Humans; Naltrexone; Narcotic Antagonists; Primary Health Care; Psychotherapy; Research Design; Taurine; United States	2000
Animal models of craving for ethanol. Addiction (Abingdon, England), 2000, Volume: 95 Suppl 2 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Animals; Behavior, Addictive; Conditioning, Operant; Disease Models, Animal; Drug Tolerance; Motivation; Naltrexone; Narcotic Antagonists; Predictive Value of Tests; Rats; Reinforcement, Psychology; Reproducibility of Results; Substance Withdrawal Syndrome; Taurine	2000

Trials

20 trial(s) available for acamprosate and Alcohol Drinking

Article	Year
World Health Organization risk drinking level reductions are associated with improved functioning and are sustained among patients with mild, moderate and severe alcohol dependence in clinical trials in the United States and United Kingdom. Addiction (Abingdon, England), 2020, Volume: 115, Issue:9 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcohol-Related Disorders; Alcoholism; Behavior Therapy; Female; Health Surveys; Humans; Male; Mental Health; Middle Aged; Motivational Interviewing; Naltrexone; Risk; Treatment Outcome; United Kingdom; United States; World Health Organization	2020
Precision Medicine in Alcohol Dependence: A Controlled Trial Testing Pharmacotherapy Response Among Reward and Relief Drinking Phenotypes. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018, Volume: 43, Issue:4 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Phenotype; Precision Medicine; Reward; Treatment Outcome	2018
Modeling longitudinal drinking data in clinical trials: an application to the COMBINE study. Drug and alcohol dependence, 2013, Sep-01, Volume: 132, Issue:1-2 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Cognitive Behavioral Therapy; Combined Modality Therapy; Data Interpretation, Statistical; Disease Progression; Female; Humans; Longitudinal Studies; Male; Models, Statistical; Naltrexone; Narcotic Antagonists; Poisson Distribution; Risk-Taking; Taurine; Temperance; Treatment Outcome	2013
What happens when people discontinue taking medications? Lessons from COMBINE. Addiction (Abingdon, England), 2014, Volume: 109, Issue:12 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Behavior Therapy; Combined Modality Therapy; Cross-Sectional Studies; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Medication Adherence; Middle Aged; Naltrexone; Patient Dropouts; Recurrence; Taurine	2014
Pain as a predictor of heavy drinking and any drinking lapses in the COMBINE study and the UK Alcohol Treatment Trial. Addiction (Abingdon, England), 2015, Volume: 110, Issue:8 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcohol-Related Disorders; Behavior Therapy; Chronic Pain; Combined Modality Therapy; Female; Humans; Male; Naltrexone; Pain Measurement; Recurrence; Taurine; Treatment Outcome	2015
Reward and relief dimensions of temptation to drink: construct validity and role in predicting differential benefit from acamprosate and naltrexone. Addiction biology, 2017, Volume: 22, Issue:6 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Reproducibility of Results; Reward; Taurine; Treatment Outcome	2017
Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study. Alcoholism, clinical and experimental research, 2009, Volume: 33, Issue:9 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Behavior Therapy; Blood Glucose; Counseling; Female; Humans; Male; Middle Aged; Naltrexone; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Taurine	2009
The effect of acamprosate on alcohol craving and correlation with hypothalamic pituitary adrenal (HPA) axis hormones and beta-endorphin. Brain research, 2009, Dec-11, Volume: 1305 Suppl Topics: Acamprosate; Adrenocorticotropic Hormone; Alcohol Deterrents; Alcohol Drinking; Alcohol-Related Disorders; beta-Endorphin; Double-Blind Method; Female; Hormones; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Pituitary-Adrenal System; Taurine; Time Factors; Treatment Outcome	2009
Network support as a prognostic indicator of drinking outcomes: the COMBINE Study. Journal of studies on alcohol and drugs, 2010, Volume: 71, Issue:6 Topics: Acamprosate; Adult; Alcohol Drinking; Alcoholism; Female; Humans; Male; Naltrexone; Prognosis; Social Support; Taurine; Temperance; Treatment Outcome	2010
Does family history of alcoholism moderate naltrexone's effects on alcohol use? Journal of studies on alcohol and drugs, 2011, Volume: 72, Issue:1 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Behavior Therapy; Family; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Compliance; Placebos; Sex Characteristics; Substance-Related Disorders; Taurine; Treatment Outcome	2011
Moderating effects of a craving intervention on the relation between negative mood and heavy drinking following treatment for alcohol dependence. Journal of consulting and clinical psychology, 2011, Volume: 79, Issue:1 Topics: Acamprosate; Adult; Affect; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Behavior Therapy; Combined Modality Therapy; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Taurine; Treatment Outcome	2011
Marked reduction of heavy drinking did not reduce nicotine use over 1 year in a clinical sample of alcohol-dependent patients. Pharmacopsychiatry, 2011, Volume: 44, Issue:3 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Cognitive Behavioral Therapy; Ethanol; Female; Humans; Male; Nicotinic Agonists; Smoking; Taurine; Temperance; Tobacco Use Disorder	2011
Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence. The Journal of nervous and mental disease, 2011, Volume: 199, Issue:7 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Cognition; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Taurine	2011
Baseline trajectories of heavy drinking and their effects on postrandomization drinking in the COMBINE Study: empirically derived predictors of drinking outcomes during treatment. Alcohol (Fayetteville, N.Y.), 2012, Volume: 46, Issue:2 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Behavior Therapy; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Naltrexone; Random Allocation; Taurine; Temperance; Treatment Outcome	2012
Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate. Alcoholism, clinical and experimental research, 2012, Volume: 36, Issue:3 Topics: Acamprosate; Adolescent; Adult; Aged; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Behavior, Addictive; Bipolar Disorder; Depression; Diagnosis, Dual (Psychiatry); Female; Humans; Male; Markov Chains; Middle Aged; Psychiatric Status Rating Scales; Taurine	2012
Simultaneous modeling of the impact of treatments on alcohol consumption and quality of life in the COMBINE study: a coupled hidden Markov analysis. Alcoholism, clinical and experimental research, 2012, Volume: 36, Issue:12 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Behavior Therapy; Combined Modality Therapy; Drug Therapy, Combination; Humans; Markov Chains; Naltrexone; Quality of Life; Taurine; Treatment Outcome	2012
The effects of drinking goal on treatment outcome for alcoholism. Journal of consulting and clinical psychology, 2013, Volume: 81, Issue:1 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Cognitive Behavioral Therapy; Female; Goals; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Recurrence; Taurine; Treatment Outcome	2013
Alcohol effects during acamprosate treatment: a dose-response study in humans. Alcoholism, clinical and experimental research, 2004, Volume: 28, Issue:7 Topics: Acamprosate; Adult; Alcohol Drinking; Alcoholic Intoxication; Analysis of Variance; Dose-Response Relationship, Drug; Double-Blind Method; Ethanol; Female; Humans; Male; Middle Aged; Psychomotor Performance; Taurine	2004
Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence. Archives of general psychiatry, 1996, Volume: 53, Issue:8 Topics: Acamprosate; Adult; Aged; Alcohol Drinking; Alcoholism; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Dropouts; Placebos; Recurrence; Survival Analysis; Taurine; Temperance; Treatment Outcome	1996
Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol and alcoholism (Oxford, Oxfordshire), 1990, Volume: 25, Issue:6 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcohol Withdrawal Delirium; Alcoholism; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Liver Function Tests; Male; Middle Aged; Taurine	1990

Other Studies

56 other study(ies) available for acamprosate and Alcohol Drinking

Article	Year
Genetic variants associated with acamprosate treatment response in alcohol use disorder patients: A multiple omics study. British journal of pharmacology, 2022, Volume: 179, Issue:13 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Ethanol; Genome-Wide Association Study; Humans; Taurine	2022
Examining a brief measure and observed cutoff scores to identify reward and relief drinking profiles: Psychometric properties and pharmacotherapy response. Drug and alcohol dependence, 2022, 03-01, Volume: 232 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Female; Humans; Male; Naltrexone; Psychometrics; Reward	2022
Acamprosate may be safer than baclofen for the treatment of alcohol use disorder in patients with cirrhosis: a first description of use in real-world clinical practice. European journal of gastroenterology & hepatology, 2022, 05-01, Volume: 34, Issue:5 Topics: Acamprosate; Alcohol Drinking; Alcoholism; Baclofen; Humans; Liver Cirrhosis; Retrospective Studies	2022
Acamprosate better than baclofen for alcohol use disorder in cirrhosis: fact or myth? European journal of gastroenterology & hepatology, 2022, 06-01, Volume: 34, Issue:6 Topics: Acamprosate; Alcohol Drinking; Alcoholism; Baclofen; Humans; Liver Cirrhosis	2022
Response to 'acamprosate better than baclofen for alcohol use disorder in cirrhosis: fact or myth?' European journal of gastroenterology & hepatology, 2022, 09-01, Volume: 34, Issue:9 Topics: Acamprosate; Alcohol Drinking; Alcoholism; Baclofen; Humans; Liver Cirrhosis	2022
[Medical management of alcohol use disorders]. La Revue du praticien, 2019, Volume: 69, Issue:8 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Baclofen; Humans	2019
TSPAN5 influences serotonin and kynurenine: pharmacogenomic mechanisms related to alcohol use disorder and acamprosate treatment response. Molecular psychiatry, 2021, Volume: 26, Issue:7 Topics: Acamprosate; Alcohol Drinking; Alcoholism; Depressive Disorder, Major; Humans; Induced Pluripotent Stem Cells; Kynurenine; Neuroinflammatory Diseases; Pharmacogenetics; Serotonin; Tetraspanins; Tryptophan Hydroxylase	2021
Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects. Scientific reports, 2017, 05-31, Volume: 7, Issue:1 Topics: Acamprosate; Adult; Alcohol Drinking; Alcoholism; Biomarkers; Female; Humans; Male; Metabolomics; Middle Aged; Precision Medicine; Treatment Outcome	2017
Commentary on Palpacuer et al. (2018): Do small effects on total alcohol consumption translate into clinical practice? Addiction (Abingdon, England), 2018, Volume: 113, Issue:2 Topics: Acamprosate; Alcohol Drinking; Alcoholism; Baclofen; Humans; Naltrexone; Narcotic Antagonists; Network Meta-Analysis; Topiramate	2018
Calcium chloride mimics the effects of acamprosate on cognitive deficits in chronic alcohol-exposed mice. Psychopharmacology, 2018, Volume: 235, Issue:7 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Attention; Calcium Chloride; Central Nervous System Depressants; Cognition; Cognitive Dysfunction; Ethanol; Male; Mice; Recognition, Psychology; Recurrence	2018
Acamprosate {monocalcium bis(3-acetamidopropane-1-sulfonate)} reduces ethanol-drinking behavior in rats and glutamate-induced toxicity in ethanol-exposed primary rat cortical neuronal cultures. European journal of pharmacology, 2013, Oct-15, Volume: 718, Issue:1-3 Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Acamprosate; Alcohol Drinking; Animals; Behavior, Animal; Cells, Cultured; Cerebral Cortex; Dizocilpine Maleate; Ethanol; Glutamic Acid; Lactate Dehydrogenases; Male; Neurons; Neuroprotective Agents; Neurotoxins; Nifedipine; Pyridines; Rats; Rats, Wistar; Signal Transduction; Taurine	2013
Predictors of abstinence from heavy drinking during treatment in COMBINE and external validation in PREDICT. Alcoholism, clinical and experimental research, 2014, Volume: 38, Issue:10 Topics: Acamprosate; Age Factors; Alcohol Abstinence; Alcohol Deterrents; Alcohol Drinking; Behavior Therapy; Combined Modality Therapy; Controlled Clinical Trials as Topic; Decision Trees; gamma-Glutamyltransferase; Germany; Goals; Humans; Logistic Models; Middle Aged; Naltrexone; Predictive Value of Tests; Randomized Controlled Trials as Topic; Reproducibility of Results; Taurine; Time Factors; Treatment Outcome; United States	2014
Comparison of dehydroepiandrosterone (DHEA) and pregnanolone with existing pharmacotherapies for alcohol abuse on ethanol- and food-maintained responding in male rats. Alcohol (Fayetteville, N.Y.), 2015, Volume: 49, Issue:2 Topics: Acamprosate; Alcohol Drinking; Alcoholism; Animals; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Eating; Ethanol; Male; Naltrexone; Pregnanolone; Rats; Rats, Long-Evans; Self Administration; Taurine	2015
Effects of acamprosate on attentional set-shifting and cellular function in the prefrontal cortex of chronic alcohol-exposed mice. Alcoholism, clinical and experimental research, 2015, Volume: 39, Issue:6 Topics: Acamprosate; Action Potentials; Alcohol Drinking; Alcoholism; Animals; Attention; Ethanol; Membrane Potentials; Mice; Prefrontal Cortex; Pyramidal Cells; Synaptic Transmission; Taurine	2015
Factors Affecting Ethanol-Induced Conditioned Place Preference and Locomotor Sensitization in Mice. Biological & pharmaceutical bulletin, 2015, Volume: 38, Issue:12 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Association Learning; Conditioning, Psychological; Ethanol; Locomotion; Male; Mice, Inbred DBA; Motor Activity; Reward; Risk Factors; Taurine	2015
Association between a brief alcohol craving measure and drinking in the following week. Addiction (Abingdon, England), 2016, Volume: 111, Issue:6 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Cognitive Behavioral Therapy; Craving; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Odds Ratio; Randomized Controlled Trials as Topic; Taurine; United States	2016
Combined Effects of Acamprosate and Escitalopram on Ethanol Consumption in Mice. Alcoholism, clinical and experimental research, 2016, Volume: 40, Issue:7 Topics: Acamprosate; Alcohol Drinking; Animals; Anxiety; Citalopram; Depression; Drug Therapy, Combination; Male; Mice; Stress, Psychological; Taurine	2016
Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats. Alcoholism, clinical and experimental research, 2008, Volume: 32, Issue:10 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Animals; Ethanol; Male; Models, Animal; Naltrexone; Narcotic Antagonists; Rats; Rats, Long-Evans; Rats, Wistar; Taurine; Time Factors	2008
Acute effects of acamprosate and MPEP on ethanol Drinking-in-the-Dark in male C57BL/6J mice. Alcoholism, clinical and experimental research, 2008, Volume: 32, Issue:11 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Darkness; Disease Models, Animal; Dose-Response Relationship, Drug; Food Deprivation; Male; Mice; Mice, Inbred C57BL; Pyridines; Receptors, Metabotropic Glutamate; Signal Transduction; Taurine	2008
Acamprosate and naltrexone treatment effects on ethanol and sucrose seeking and intake in ethanol-dependent and nondependent rats. Psychopharmacology, 2009, Volume: 204, Issue:2 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Body Weight; Conditioning, Operant; Data Interpretation, Statistical; Male; Naltrexone; Rats; Rats, Long-Evans; Sucrose; Taste; Taurine	2009
Glycine receptors in the nucleus accumbens involved in the ethanol intake-reducing effect of acamprosate. Alcoholism, clinical and experimental research, 2010, Volume: 34, Issue:1 Topics: Acamprosate; Alcohol Drinking; Animals; Dopamine; Ethanol; Male; Microinjections; Nucleus Accumbens; Protein Binding; Rats; Rats, Wistar; Receptors, Glycine; Taurine	2010
Alcohol dependence: after the withdrawal phase. Long-term abstinence: better health and psychosocial status. Psychosocial support for a chronic disorder. Some drugs are useful adjuncts to medical support. Prescrire international, 2009, Volume: 18, Issue:103 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcohol-Related Disorders; Alcoholics; Alcoholism; Anticonvulsants; Baclofen; Clinical Trials as Topic; Combined Modality Therapy; Disulfiram; France; Fructose; Health Status; Humans; Naltrexone; Psychotherapy; Randomized Controlled Trials as Topic; Secondary Prevention; Self-Help Groups; Social Support; Taurine; Temperance; Topiramate; Treatment Outcome	2009
Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study. Drug and alcohol dependence, 2010, Mar-01, Volume: 107, Issue:2-3 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Behavior Therapy; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Odds Ratio; Randomized Controlled Trials as Topic; Taurine; Treatment Outcome; United States	2010
Glycine transporter-1 blockade leads to persistently reduced relapse-like alcohol drinking in rats. Biological psychiatry, 2010, Oct-15, Volume: 68, Issue:8 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Corpus Striatum; Disease Models, Animal; Gene Expression Profiling; Glycine Plasma Membrane Transport Proteins; Male; Rats; Rats, Wistar; Secondary Prevention; Signal Transduction; Taurine; Tetrahydronaphthalenes	2010
Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials. Alcoholism, clinical and experimental research, 2010, Volume: 34, Issue:12 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Female; Fructose; Humans; Male; Naltrexone; Randomized Controlled Trials as Topic; Taurine; Temperance; Time Factors; Topiramate; Treatment Outcome	2010
Acamprosate reduces ethanol drinking behaviors and alters the metabolite profile in mice lacking ENT1. Neuroscience letters, 2011, Feb-25, Volume: 490, Issue:2 Topics: Acamprosate; Alcohol Drinking; Animals; Equilibrative Nucleoside Transporter 1; Ethanol; Glutamic Acid; Male; Metabolome; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Nucleus Accumbens; Taurine; Up-Regulation	2011
Acamprosate-responsive brain sites for suppression of ethanol intake and preference. American journal of physiology. Regulatory, integrative and comparative physiology, 2011, Volume: 301, Issue:4 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Animals; Brain; Circadian Rhythm; Drinking; Food Preferences; Hippocampus; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Models, Animal; Motor Activity; Nucleus Accumbens; Pedunculopontine Tegmental Nucleus; Period Circadian Proteins; Suprachiasmatic Nucleus; Taurine; Ventral Tegmental Area	2011
Circadian and acamprosate modulation of elevated ethanol drinking in mPer2 clock gene mutant mice. Chronobiology international, 2011, Volume: 28, Issue:8 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Animals; Circadian Rhythm; Ethanol; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Period Circadian Proteins; Taurine	2011
The glycine reuptake inhibitor Org24598 and acamprosate reduce ethanol intake in the rat; tolerance development to acamprosate but not to Org24598. Addiction biology, 2012, Volume: 17, Issue:5 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Animals; beta-Alanine; Dopamine; Drug Tolerance; Glycine; Glycine Plasma Membrane Transport Proteins; Male; Nucleus Accumbens; Rats; Rats, Wistar; Taurine	2012
Cocaine reverses the naltrexone-induced reduction in operant ethanol self-administration: the effects on immediate-early gene expression in the rat prefrontal cortex. Neuropharmacology, 2012, Volume: 63, Issue:6 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Animals; Carrier Proteins; Cocaine; Conditioning, Operant; Cyclooxygenase 2; Dose-Response Relationship, Drug; Gene Expression; Genes, fos; Genes, Immediate-Early; Homer Scaffolding Proteins; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Prefrontal Cortex; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Self Administration; Taurine	2012
[Deficits in preventing recurrence in alcoholic patients. Withdrawal--and immediately back to the bottle]. MMW Fortschritte der Medizin, 2003, Jan-16, Volume: 145, Issue:1-2 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Clinical Trials as Topic; Combined Modality Therapy; Follow-Up Studies; Humans; Receptors, N-Methyl-D-Aspartate; Secondary Prevention; Taurine	2003
Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2003, Volume: 28, Issue:8 Topics: Acamprosate; Alcohol Drinking; Animals; Behavior, Addictive; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethanol; Male; Naltrexone; Rats; Rats, Wistar; Taurine; Temperance	2003
Effect of the combination of naltrexone and acamprosate on alcohol intake in mice. Psychiatry and clinical neurosciences, 2004, Volume: 58, Issue:1 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Dose-Response Relationship, Drug; Drug Therapy, Combination; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Taurine	2004
Does acamprosate improve reduction of drinking as well as aiding abstinence? Journal of psychopharmacology (Oxford, England), 2003, Volume: 17, Issue:4 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Clinical Trials as Topic; Humans; Secondary Prevention; Taurine; Temperance	2003
The mosaic of addiction. The American journal of psychiatry, 2004, Volume: 161, Issue:10 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Behavior, Addictive; Disease Models, Animal; Endorphins; Ethanol; Euphoria; Humans; Naltrexone; Receptors, Dopamine D2; Receptors, Opioid; Secondary Prevention; Taurine	2004
Ask the doctor. I need to quit drinking, but don't think I can do it on my own. Can I use a drug like Antabuse even though I have heart disease? Harvard heart letter : from Harvard Medical School, 2004, Volume: 15, Issue:2 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Contraindications; Disulfiram; Heart Diseases; Humans; Naltrexone; Taurine	2004
The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nature medicine, 2005, Volume: 11, Issue:1 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Amino Acid Transport System X-AG; Animals; Biological Clocks; Cell Cycle Proteins; Cocaine; Cocaine-Related Disorders; Glutamic Acid; Humans; Mice; Nuclear Proteins; Period Circadian Proteins; Taurine; Time Factors; Transcription Factors	2005
The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:6 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Animals; Conditioning, Operant; Cues; Cyclopentanes; Extinction, Psychological; Injections, Intraperitoneal; Male; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Recurrence; Taurine	2005
Acamprosate involvement in triacylglycerol hydrolysis and transacylation with cholesterol in chronically ethanol-drinking rats. Journal of basic and clinical physiology and pharmacology, 2004, Volume: 15, Issue:3-4 Topics: Acamprosate; Acylation; Alcohol Deterrents; Alcohol Drinking; Animals; Cholesterol; Ethanol; Hydrolysis; Male; Rats; Rats, Wistar; Sterol O-Acyltransferase; Taurine; Triglycerides	2004
Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone. Addiction biology, 2006, Volume: 11, Issue:1 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Appetitive Behavior; Dose-Response Relationship, Drug; Drinking; Hunger; Injections, Intraperitoneal; Male; Mice; Mice, Inbred Strains; Naltrexone; Reinforcement Schedule; Taurine; Thirst	2006
Effects of treatment with acamprosate on beta-endorphin plasma concentration in humans with high alcohol preference. Neuroscience letters, 2006, Aug-14, Volume: 404, Issue:1-2 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; beta-Endorphin; Biomarkers; Female; Humans; Male; Middle Aged; Placebos; Rats; Taurine	2006
[Maintaining abstinence after alcohol detoxification]. La Revue du praticien, 2006, May-31, Volume: 56, Issue:10 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Ambulatory Care; Behavior Therapy; Clinical Protocols; Cognitive Behavioral Therapy; Disulfiram; Follow-Up Studies; Humans; Naltrexone; Patient Care Planning; Psychoanalytic Therapy; Psychotherapy, Group; Psychotropic Drugs; Social Support; Taurine; Temperance	2006
Influence of age at drinking onset on the alcohol deprivation effect and stress-induced drinking in female rats. Pharmacology, biochemistry, and behavior, 2007, Volume: 86, Issue:2 Topics: Acamprosate; Age of Onset; Aging; Alcohol Deterrents; Alcohol Drinking; Animals; Central Nervous System Depressants; Electroshock; Ethanol; Female; Rats; Rats, Wistar; Stress, Psychological; Substance Withdrawal Syndrome; Swimming; Taurine	2007
Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice. Addiction biology, 2007, Volume: 12, Issue:1 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Conditioning, Operant; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Naltrexone; Nitriles; Receptors, Dopamine D3; Taurine; Tetrahydroisoquinolines	2007
Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions. The international journal of neuropsychopharmacology, 2008, Volume: 11, Issue:6 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Analysis of Variance; Animals; Behavior, Animal; Central Nervous System Depressants; Choice Behavior; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Excitatory Amino Acid Antagonists; Female; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Reflex; Self Administration; Sex Factors; Taurine	2008
A homotaurine derivative reduces the voluntary intake of ethanol by rats: are cerebral GABA receptors involved? Pharmacology, biochemistry, and behavior, 1984, Volume: 21, Issue:5 Topics: Acamprosate; Alcohol Drinking; Animals; Anticonvulsants; Brain; Calcium Chloride; Male; Rats; Receptors, GABA-A; Taurine	1984
Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. European journal of pharmacology, 1996, Jun-03, Volume: 305, Issue:1-3 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Animals; Dose-Response Relationship, Drug; Ethanol; Injections, Intraperitoneal; Male; Rats; Rats, Wistar; Taurine; Time Factors	1996
Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1998, Volume: 18, Issue:2 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Animals; Central Nervous System Depressants; Conditioning, Operant; Dose-Response Relationship, Drug; Ethanol; Male; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Taurine	1998
Occurrence and management of depression in the context of naltrexone treatment of alcoholism. The American journal of psychiatry, 1999, Volume: 156, Issue:8 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Comorbidity; Depressive Disorder; Diagnosis, Dual (Psychiatry); Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors; Taurine	1999
Effects of acamprosate on ethanol-seeking and self-administration in the rat. Alcoholism, clinical and experimental research, 2001, Volume: 25, Issue:3 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Animals; Male; Rats; Rats, Long-Evans; Reinforcement, Psychology; Self Administration; Taurine	2001
Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption. Alcohol (Fayetteville, N.Y.), 2001, Volume: 23, Issue:2 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Animals; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Taurine	2001
Effects of acamprosate on sensitization to the locomotor-stimulant effects of alcohol in mice selectively bred for high and low alcohol preference. Behavioural pharmacology, 2001, Volume: 12, Issue:6-7 Topics: Acamprosate; Alcohol Drinking; Animals; Drug Interactions; Ethanol; Female; Genotype; Male; Mice; Mice, Inbred Strains; Motor Activity; Selection, Genetic; Taurine	2001
Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release. European journal of pharmacology, 2002, Feb-15, Volume: 437, Issue:1-2 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Animals; Central Nervous System Depressants; Dopamine; Dose-Response Relationship, Drug; Ethanol; Male; Nucleus Accumbens; Rats; Rats, Long-Evans; Taurine	2002
Triptosine, an L-5-hydroxytryptophan derivative, reduces alcohol consumption in alcohol-preferring rats. Alcohol and alcoholism (Oxford, Oxfordshire), 1992, Volume: 27, Issue:3 Topics: 5-Hydroxytryptophan; Acamprosate; Alcohol Deterrents; Alcohol Drinking; Animals; Appetite; Brain; Dose-Response Relationship, Drug; Drug Combinations; Inosine; Male; Rats; Receptors, Serotonin; Serotonin; Taurine	1992
Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour. Alcohol and alcoholism (Oxford, Oxfordshire), 1991, Volume: 26, Issue:2 Topics: Acamprosate; Administration, Inhalation; Alcohol Drinking; Alcoholic Intoxication; Alcoholism; Animals; Arousal; Cerebral Cortex; Diazepam; Dose-Response Relationship, Drug; Energy Metabolism; Ethanol; gamma-Aminobutyric Acid; Motor Activity; Oxygen Consumption; Rats; Receptors, GABA-A; Regional Blood Flow; Substance Withdrawal Syndrome; Taurine	1991
Noradrenaline and GABA brain receptors are co-involved in the voluntary intake of ethanol by rats. Alcohol and alcoholism (Oxford, Oxfordshire). Supplement, 1987, Volume: 1 Topics: Acamprosate; Alcohol Drinking; Animals; Bicuculline; Brain; Dibenzazepines; Male; Rats; Receptors, Adrenergic; Receptors, GABA-A; Taurine	1987